Leadless pacing: Presente e Futuro della stimolazione cardiaca

Agostino Piro, Carlo Lavalle, Domenico G. Della Rocca, Paola Scarparo, Massimo Mancone, Viviana Maestrini, Luigi Di Biase, Andrea Natale, Francesco Fedele

Research output: Contribution to journalReview article

Abstract

Leadless pacemaker therapy now represents a reality in the field of cardiac pacing. It was developed with the aim of reducing post-procedural complications due to endocavitary leads and with the intention to propose itself as a valid alternative in patients who have contraindications to conventional pacing. Leadless pacemakers to date allow right ventricular stimulation and are implanted through a percutaneous venous femoral access. Currently, the system available is the MicraTM Transcatheter Pacing System. On November 2017, the worldwide implants of the NanostimTM Leadless Pacemaker System were halted. These devices have shown promising results in the various clinical trials with complications mostly due to the implant procedure. In order to avoid these complications, a correct learning curve of the operators has resulted very important. Recently, a new system, the WiSE-CRT, has been introduced as a leadless alternative to cardiac resynchronization therapy. While the results of randomized trials and long-term follow-up studies are still pending, in this paper we will review the main clinical data that have been published to date, comparing them to the traditional devices for transvenous endocardial stimulation.

Original languageItalian
Pages (from-to)32-40
Number of pages9
JournalGiornale Italiano di Cardiologia
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Cardiac Resynchronization Therapy
Bradycardia
Cardiac Arrhythmias
Equipment and Supplies
Learning Curve
Thigh
Clinical Trials
Therapeutics

Keywords

  • Bradyarrhythmias
  • Cardiac arrhythmias
  • Cardiac pacing
  • Cardiac resynchronization therapy
  • Leadless pacemaker
  • Transvenous leads
  • Transvenous pacemaker

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Piro, A., Lavalle, C., Della Rocca, D. G., Scarparo, P., Mancone, M., Maestrini, V., ... Fedele, F. (2019). Leadless pacing: Presente e Futuro della stimolazione cardiaca. Giornale Italiano di Cardiologia, 20(1), 32-40. https://doi.org/10.1714/3079.30718

Leadless pacing : Presente e Futuro della stimolazione cardiaca. / Piro, Agostino; Lavalle, Carlo; Della Rocca, Domenico G.; Scarparo, Paola; Mancone, Massimo; Maestrini, Viviana; Di Biase, Luigi; Natale, Andrea; Fedele, Francesco.

In: Giornale Italiano di Cardiologia, Vol. 20, No. 1, 01.01.2019, p. 32-40.

Research output: Contribution to journalReview article

Piro, A, Lavalle, C, Della Rocca, DG, Scarparo, P, Mancone, M, Maestrini, V, Di Biase, L, Natale, A & Fedele, F 2019, 'Leadless pacing: Presente e Futuro della stimolazione cardiaca' Giornale Italiano di Cardiologia, vol. 20, no. 1, pp. 32-40. https://doi.org/10.1714/3079.30718
Piro A, Lavalle C, Della Rocca DG, Scarparo P, Mancone M, Maestrini V et al. Leadless pacing: Presente e Futuro della stimolazione cardiaca. Giornale Italiano di Cardiologia. 2019 Jan 1;20(1):32-40. https://doi.org/10.1714/3079.30718
Piro, Agostino ; Lavalle, Carlo ; Della Rocca, Domenico G. ; Scarparo, Paola ; Mancone, Massimo ; Maestrini, Viviana ; Di Biase, Luigi ; Natale, Andrea ; Fedele, Francesco. / Leadless pacing : Presente e Futuro della stimolazione cardiaca. In: Giornale Italiano di Cardiologia. 2019 ; Vol. 20, No. 1. pp. 32-40.
@article{312439f99ea3428880ebd15f5290f6d3,
title = "Leadless pacing: Presente e Futuro della stimolazione cardiaca",
abstract = "Leadless pacemaker therapy now represents a reality in the field of cardiac pacing. It was developed with the aim of reducing post-procedural complications due to endocavitary leads and with the intention to propose itself as a valid alternative in patients who have contraindications to conventional pacing. Leadless pacemakers to date allow right ventricular stimulation and are implanted through a percutaneous venous femoral access. Currently, the system available is the MicraTM Transcatheter Pacing System. On November 2017, the worldwide implants of the NanostimTM Leadless Pacemaker System were halted. These devices have shown promising results in the various clinical trials with complications mostly due to the implant procedure. In order to avoid these complications, a correct learning curve of the operators has resulted very important. Recently, a new system, the WiSE-CRT, has been introduced as a leadless alternative to cardiac resynchronization therapy. While the results of randomized trials and long-term follow-up studies are still pending, in this paper we will review the main clinical data that have been published to date, comparing them to the traditional devices for transvenous endocardial stimulation.",
keywords = "Bradyarrhythmias, Cardiac arrhythmias, Cardiac pacing, Cardiac resynchronization therapy, Leadless pacemaker, Transvenous leads, Transvenous pacemaker",
author = "Agostino Piro and Carlo Lavalle and {Della Rocca}, {Domenico G.} and Paola Scarparo and Massimo Mancone and Viviana Maestrini and {Di Biase}, Luigi and Andrea Natale and Francesco Fedele",
year = "2019",
month = "1",
day = "1",
doi = "10.1714/3079.30718",
language = "Italian",
volume = "20",
pages = "32--40",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "1",

}

TY - JOUR

T1 - Leadless pacing

T2 - Presente e Futuro della stimolazione cardiaca

AU - Piro, Agostino

AU - Lavalle, Carlo

AU - Della Rocca, Domenico G.

AU - Scarparo, Paola

AU - Mancone, Massimo

AU - Maestrini, Viviana

AU - Di Biase, Luigi

AU - Natale, Andrea

AU - Fedele, Francesco

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Leadless pacemaker therapy now represents a reality in the field of cardiac pacing. It was developed with the aim of reducing post-procedural complications due to endocavitary leads and with the intention to propose itself as a valid alternative in patients who have contraindications to conventional pacing. Leadless pacemakers to date allow right ventricular stimulation and are implanted through a percutaneous venous femoral access. Currently, the system available is the MicraTM Transcatheter Pacing System. On November 2017, the worldwide implants of the NanostimTM Leadless Pacemaker System were halted. These devices have shown promising results in the various clinical trials with complications mostly due to the implant procedure. In order to avoid these complications, a correct learning curve of the operators has resulted very important. Recently, a new system, the WiSE-CRT, has been introduced as a leadless alternative to cardiac resynchronization therapy. While the results of randomized trials and long-term follow-up studies are still pending, in this paper we will review the main clinical data that have been published to date, comparing them to the traditional devices for transvenous endocardial stimulation.

AB - Leadless pacemaker therapy now represents a reality in the field of cardiac pacing. It was developed with the aim of reducing post-procedural complications due to endocavitary leads and with the intention to propose itself as a valid alternative in patients who have contraindications to conventional pacing. Leadless pacemakers to date allow right ventricular stimulation and are implanted through a percutaneous venous femoral access. Currently, the system available is the MicraTM Transcatheter Pacing System. On November 2017, the worldwide implants of the NanostimTM Leadless Pacemaker System were halted. These devices have shown promising results in the various clinical trials with complications mostly due to the implant procedure. In order to avoid these complications, a correct learning curve of the operators has resulted very important. Recently, a new system, the WiSE-CRT, has been introduced as a leadless alternative to cardiac resynchronization therapy. While the results of randomized trials and long-term follow-up studies are still pending, in this paper we will review the main clinical data that have been published to date, comparing them to the traditional devices for transvenous endocardial stimulation.

KW - Bradyarrhythmias

KW - Cardiac arrhythmias

KW - Cardiac pacing

KW - Cardiac resynchronization therapy

KW - Leadless pacemaker

KW - Transvenous leads

KW - Transvenous pacemaker

UR - http://www.scopus.com/inward/record.url?scp=85059900759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059900759&partnerID=8YFLogxK

U2 - 10.1714/3079.30718

DO - 10.1714/3079.30718

M3 - Review article

VL - 20

SP - 32

EP - 40

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 1

ER -